Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have received an average recommendation of “Moderate Buy” from the five analysts that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is GBX 2,298.33.
Several research analysts recently commented on JMAT shares. Jefferies Financial Group restated a “restricted” rating on shares of Johnson Matthey in a report on Friday, May 29th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 2,400 price objective on shares of Johnson Matthey in a research report on Monday, July 6th. UBS Group reissued a “neutral” rating and issued a GBX 2,200 target price on shares of Johnson Matthey in a research note on Friday, May 22nd. Finally, Berenberg Bank lifted their target price on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a report on Monday, June 1st.
Read Our Latest Analysis on Johnson Matthey
Johnson Matthey Trading Up 0.5%
Johnson Matthey (LON:JMAT – Get Free Report) last released its quarterly earnings data on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%.The business had revenue of GBX 1,257.30 billion for the quarter. As a group, equities analysts expect that Johnson Matthey will post 173.4112903 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, insider Richard Pike acquired 14 shares of the business’s stock in a transaction on Wednesday, June 10th. The shares were bought at an average cost of GBX 1,990 per share, with a total value of £278.60. Also, insider Liam Condon acquired 4,500 shares of Johnson Matthey stock in a transaction on Monday, June 1st. The shares were bought at an average price of GBX 2,127 per share, for a total transaction of £95,715. Over the last three months, insiders purchased 11,470 shares of company stock valued at $24,671,344. 0.58% of the stock is owned by company insiders.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
See Also
- Five stocks we like better than Johnson Matthey
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
